2 years ago
MRNA
AnalystsTyler Van BurenTyler Van Buren's Stock Forecasts
AnalystsTyler Van Buren
Analyst Ranking
Bottom 7%
#4558 out of 4861 analysts
Average Return
-16%
Win Rate
32%14 out of 44
Risk vs Reward
Poor
Good
Tyler Van Buren's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neurogene IncNGNE | +60.57% | $175.00 | $281.00 | 2020-01-10 - 2021-01-08 | Strong Buy |
Gilead Sciences IncGILD | +59.80% | $65.42 | $104.54 | 2024-04-26 - 2025-04-17 | Strong Buy |
Reata Pharmaceuticals IncRETA | +59.76% | $107.89 | $172.36 | 2023-07-06 - 2023-09-25 | Buy |
Alder Biopharmaceuticals IncALDR | +49.33% | $11.15 | $16.65 | 2017-09-26 - 2018-09-26 | Buy |
Regeneron Pharmaceuticals IncREGN | +29.78% | $736.46 | $955.80 | 2023-01-30 - 2024-01-29 | Buy |
Tyler Van Buren Analyst Color
Get additional color on Tyler Van Buren's coverage of popular stocks
3 years ago
MRNA
Tyler Van Buren's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biohaven LtdBHVN | 2 | Strong Buy | $75.00 | +268.19% | Maintains | 5 months ago |
Moderna IncMRNA | 6 | Hold | $60.00 | +142.77% | Maintains | 7 months ago |
Regeneron Pharmaceuticals IncREGN | 7 | Strong Buy | $1,200.00 | +113.08% | Maintains | 9 months ago |
Gilead Sciences IncGILD | 3 | Strong Buy | $85.00 | -18.69% | Maintains | a year ago |
Crispr Therapeutics AgCRSP | 2 | Sell | $30.00 | N/A | Downgrades | a year ago |
Reata Pharmaceuticals IncRETA | 1 | Buy | $140.00 | N/A | Initiates Coverage On | 2 years ago |
Travere Therapeutics IncTVTX | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Deciphera Pharmaceuticals IncDCPH | 2 | Buy | $30.00 | N/A | Maintains | 2 years ago |
Immunocore Holdings PLCIMCR | 1 | Buy | $70.00 | N/A | Initiates Coverage On | 3 years ago |
Zentalis Pharmaceuticals IncZNTL | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Turning Point Therapeutics IncTPTX | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Fate Therapeutics IncFATE | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Arvinas IncARVN | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Tyra Biosciences IncTYRA | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Essa Pharma IncEPIX | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Gyre Therapeutics IncGYRE | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Gracell Biotechnologies IncGRCL | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Aligos Therapeutics IncALGS | 1 | Strong Buy | $875.00 | N/A | Initiates Coverage On | 4 years ago |
Beigene LtdONC | 2 | Strong Sell | $185.00 | N/A | Downgrades | 4 years ago |
Mirati Therapeutics IncMRTX | 1 | Strong Buy | $210.00 | N/A | Maintains | 4 years ago |
Inozyme Pharma IncINZY | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Nurix Therapeutics IncNRIX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Neurogene IncNGNE | 2 | Strong Buy | $150.00 | N/A | Maintains | 5 years ago |
Tcr2 Therapeutics IncTCRR | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 5 years ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Akouos IncAKUS | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Leap Therapeutics IncLPTX | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 5 years ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 5 years ago |
Harpoon Therapeutics IncHARP | 1 | Strong Buy | $350.00 | N/A | Initiates Coverage On | 5 years ago |
Gossamer Bio IncGOSS | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Theravance Biopharma IncTBPH | 1 | Strong Buy | $35.00 | N/A | Maintains | 5 years ago |
Adverum Biotechnologies IncADVM | 1 | Strong Buy | $200.00 | N/A | Reiterates | 5 years ago |
Omeros CorpOMER | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Neos Therapeutics IncNEOS | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Aerie Pharmaceuticals IncAERI | 1 | Buy | $70.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.